DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Pietrantonio F, Morano F, Corallo S, Lonardi S, Cremolini C, Rimassa L. et al.
First-line FOLFOX plus panitumumab (Pan) followed by 5FU/LV plus Pan or single-agent Pan as maintenance therapy in patients with RAS wild-type metastatic colorectal cancer: The VALENTINO study.
J Clin Oncol 2018;
36(suppl): Abstract 3505
Access:
We do not assume any responsibility for the contents of the web pages of other providers.